Cellularline SpA
MIL:CELL
Balance Sheet
Balance Sheet Decomposition
Cellularline SpA
Cellularline SpA
Balance Sheet
Cellularline SpA
| Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
3
|
11
|
131
|
42
|
32
|
9
|
16
|
20
|
28
|
21
|
|
| Cash |
2
|
11
|
0
|
0
|
32
|
9
|
8
|
10
|
14
|
0
|
|
| Cash Equivalents |
0
|
0
|
131
|
42
|
0
|
0
|
8
|
10
|
14
|
21
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
74
|
0
|
65
|
65
|
54
|
53
|
54
|
52
|
57
|
|
| Accounts Receivables |
0
|
69
|
0
|
59
|
61
|
53
|
52
|
53
|
51
|
56
|
|
| Other Receivables |
0
|
5
|
0
|
6
|
4
|
2
|
1
|
1
|
0
|
0
|
|
| Inventory |
0
|
16
|
0
|
21
|
23
|
33
|
31
|
41
|
47
|
40
|
|
| Other Current Assets |
0
|
2
|
1
|
4
|
6
|
5
|
5
|
3
|
13
|
10
|
|
| Total Current Assets |
0
|
103
|
132
|
132
|
125
|
101
|
97
|
109
|
126
|
127
|
|
| PP&E Net |
0
|
9
|
0
|
7
|
9
|
10
|
9
|
12
|
12
|
11
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
9
|
10
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
9
|
10
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
3
|
0
|
79
|
76
|
75
|
61
|
55
|
51
|
43
|
|
| Goodwill |
0
|
75
|
0
|
94
|
95
|
106
|
109
|
34
|
39
|
38
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
1
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
1
|
2
|
2
|
5
|
5
|
6
|
6
|
|
| Other Assets |
0
|
75
|
0
|
94
|
95
|
106
|
109
|
34
|
39
|
38
|
|
| Total Assets |
0
N/A
|
190
N/A
|
132
-31%
|
313
+137%
|
307
-2%
|
294
-4%
|
281
-4%
|
215
-23%
|
233
+8%
|
226
-3%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
0
|
30
|
0
|
20
|
19
|
15
|
20
|
24
|
32
|
32
|
|
| Accrued Liabilities |
0
|
2
|
0
|
3
|
3
|
3
|
3
|
1
|
6
|
6
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
13
|
0
|
12
|
15
|
11
|
10
|
24
|
29
|
14
|
|
| Other Current Liabilities |
0
|
4
|
5
|
9
|
4
|
11
|
5
|
7
|
7
|
6
|
|
| Total Current Liabilities |
0
|
49
|
6
|
44
|
40
|
40
|
38
|
55
|
75
|
57
|
|
| Long-Term Debt |
0
|
24
|
0
|
52
|
38
|
36
|
27
|
16
|
9
|
21
|
|
| Deferred Income Tax |
0
|
0
|
0
|
21
|
21
|
3
|
2
|
3
|
4
|
1
|
|
| Other Liabilities |
0
|
2
|
0
|
2
|
5
|
7
|
8
|
11
|
12
|
9
|
|
| Total Liabilities |
0
N/A
|
75
N/A
|
6
-92%
|
118
+1 907%
|
105
-12%
|
86
-18%
|
76
-11%
|
85
+12%
|
99
+16%
|
89
-10%
|
|
| Equity | |||||||||||
| Common Stock |
0
|
7
|
13
|
21
|
21
|
21
|
21
|
21
|
21
|
21
|
|
| Retained Earnings |
0
|
25
|
113
|
173
|
181
|
187
|
184
|
109
|
113
|
116
|
|
| Additional Paid In Capital |
82
|
82
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
0
N/A
|
115
N/A
|
126
+10%
|
194
+54%
|
203
+4%
|
208
+3%
|
205
-1%
|
130
-36%
|
135
+3%
|
137
+2%
|
|
| Total Liabilities & Equity |
0
N/A
|
190
N/A
|
132
-31%
|
313
+137%
|
307
-2%
|
294
-4%
|
281
-4%
|
215
-23%
|
233
+8%
|
226
-3%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
24
|
24
|
23
|
23
|
22
|
22
|
22
|
22
|
22
|
21
|
|